| COMPANY NEWS; F.D.A. APPROVES BRISTOL-MYERS'S NEW HEPATITIS DRUG |
|
|
|
| Wednesday, 31 December 1969 | |||||||
|
Food and Drug Administration approves new Bristol-Myers Squibb treatment for chronic heaptitis B; oral antiviral treatment, Baraclude, received unanimous endorsement of FDA advisory panel on March 11; Baraclude has potential market estimated at more than $500 million (S)... Read more at: http://query.nytimes.com/gst/fullpage.html?sec=health&res=9A06E2DF133FF933A05750C0A9639C8B63&partner=rssnyt&emc=rss. | |||||||
|
|||||||
| Last Updated ( Wednesday, 09 August 2006 ) | |||||||
| < Prev | Next > |
|---|